Document is current
Any future updates will be listed below
-
Authors
Guo, Xiaolin
Liu, Liru
Luo, Jie
Peng, Tingting https://orcid.org/0000-0001-5154-599X
Wang, You
Huang, Shiya
Zeng, Xiaoli
Peng, Tingting https://orcid.org/0000-0002-7820-6610
Chen, Aihua
Zhong, Mengru
Zhang, Yage
Xu, Kaishou
-
Funding
Funding for this research was provided by:
National Nature Science Foundation of China (82472598)
Guangzhou Municipal Science and Technology Project (2024A03J01274)
the Featured Clinical Technique of Guangzhou (2023C-TS59)
- License Information
-
More Information
Article History
Received: 30 December 2024
Accepted: 18 July 2025
First Online: 21 August 2025
Declarations
:
: All procedures were approved by the Laboratory Animal Committee of Guangzhou Women and Children’s Medical Center. (1) Title of the approved project: Constraint-induced movement therapy combined with mesenchymal stem cell transplantation promotes myelination and functional recovery in hemiplegic cerebral palsy rats; (2) Name of the institutional approval committee: Laboratory Animal Committee of Guangzhou Women and Children’s Medical Center; (3) Approval number: RSDW-2023-01402; (4) Date of approval: 13th December 2023. Human material has been performed in accordance with the Declaration of Helsinki. The hUC-MSCs used in this study were all supplied by Guangdong Xiangxue Stem Cell Regenerative Medicine Technology Co., Ltd, and approved by the National Institutes for Food and Drug Control (Report number: SH202207163, Date of approval: 4th November 2022). Human umbilical cord tissue was sourced from healthy volunteer pregnant women, all of whom signed an informed consent form prior to delivery.
: Not applicable.
: The authors declare that they have no competing interests.
